Reference no: EM132016827

1. Why will a patient with Systemic Carnitine deficiency experience repeated episodes of hypoglycemia?
2. Why would there be steatosis (lipid accumulation) in th liver of a patient with Systemic Carnitine deficiency? Why will skeletal muscle carnitine content remain below normal despite high-dose carnitine therapy in this patient?
3. Give at least 3 possible explanations for a false-negative result in a patient with G6PD deficiency?
4. Distinguish in biochemical detail between peroxisomal β-oxidation of fatty acids and mitochondrial β-oxidation of fatty acids.
5. Distinguish in biochemical detail between β-oxidation of saturated and unsaturated fatty acids.